YU227181A - Process for obtaining 3-aryl-5-isothiazole derivatives - Google Patents

Process for obtaining 3-aryl-5-isothiazole derivatives

Info

Publication number
YU227181A
YU227181A YU02271/81A YU227181A YU227181A YU 227181 A YU227181 A YU 227181A YU 02271/81 A YU02271/81 A YU 02271/81A YU 227181 A YU227181 A YU 227181A YU 227181 A YU227181 A YU 227181A
Authority
YU
Yugoslavia
Prior art keywords
aryl
obtaining
isothiazole derivatives
isothiazole
derivatives
Prior art date
Application number
YU02271/81A
Other languages
English (en)
Inventor
J R Beck
R P Gajewski
R E Hackler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU227181A publication Critical patent/YU227181A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU02271/81A 1980-09-22 1981-09-21 Process for obtaining 3-aryl-5-isothiazole derivatives YU227181A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,435 US4346094A (en) 1980-09-22 1980-09-22 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

Publications (1)

Publication Number Publication Date
YU227181A true YU227181A (en) 1983-10-31

Family

ID=22697314

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02271/81A YU227181A (en) 1980-09-22 1981-09-21 Process for obtaining 3-aryl-5-isothiazole derivatives

Country Status (22)

Country Link
US (1) US4346094A (cs)
EP (1) EP0048615B1 (cs)
JP (1) JPS5785379A (cs)
KR (1) KR830007597A (cs)
AR (1) AR229103A1 (cs)
AT (1) ATE7657T1 (cs)
AU (1) AU7551681A (cs)
CS (1) CS228536B2 (cs)
DD (1) DD201790A5 (cs)
DE (1) DE3163900D1 (cs)
DK (1) DK417981A (cs)
ES (1) ES8301225A1 (cs)
FI (1) FI812940L (cs)
GB (1) GB2084573B (cs)
GR (1) GR75046B (cs)
IL (1) IL63890A0 (cs)
NO (1) NO813208L (cs)
PL (1) PL130497B1 (cs)
PT (1) PT73711B (cs)
RO (1) RO82216A (cs)
YU (1) YU227181A (cs)
ZA (1) ZA816549B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431652A (en) * 1980-12-29 1984-02-14 Merck & Co., Inc. 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4428956A (en) 1980-12-29 1984-01-31 Merck & Co., Inc. 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4539328A (en) * 1983-03-25 1985-09-03 Fmc Corporation Nematicidal isothiazole derivatives
US4620865A (en) * 1983-11-07 1986-11-04 Eli Lilly And Company Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
CA2073981C (en) * 1990-11-30 2002-01-08 Shiro Kondo 2-arylthiazole derivatives and pharmaceutical composition thereof
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
MY117352A (en) * 1995-10-31 2004-06-30 Ciba Sc Holding Ag Oximesulfonic acid esters and the use thereof as latent sulfonic acids.
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
AU1520699A (en) * 1997-11-07 1999-05-31 Johns Hopkins University, The Methods for treatment of disorders of cardiac contractility
TW575792B (en) * 1998-08-19 2004-02-11 Ciba Sc Holding Ag New unsaturated oxime derivatives and the use thereof as latent acids
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
AU2003206787A1 (en) 2002-02-06 2003-09-02 Ciba Specialty Chemicals Holding Inc. Sulfonate derivatives and the use therof as latent acids
DE602005016272D1 (de) * 2004-08-27 2009-10-08 Astellas Pharma Inc 2-phenylpyridinderivat
WO2006022375A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. ２－フェニルチオフェン誘導体
CA2621038A1 (en) 2005-10-07 2007-04-19 Astellas Pharma Inc. Triarylcarboxylic acid derivative
KR20080097456A (ko) 2006-02-24 2008-11-05 아스텔라스세이야쿠 가부시키가이샤 소화관 궤양의 치료제 또는 예방제
GB2450975B (en) 2007-07-12 2010-02-24 Ciba Holding Inc Yellow radiation curing inks
EP2291189B1 (en) * 2008-05-22 2014-10-01 AstraZeneca AB Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same
CA2752485C (en) 2009-02-27 2017-01-03 Teijin Pharma Limited Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
JP2012522084A (ja) 2009-03-30 2012-09-20 ビーエーエスエフ ソシエタス・ヨーロピア Ｕｖ線量インジケータフィルム
EP2610248B1 (en) 2010-08-27 2016-06-08 Teijin Pharma Limited Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
JP5955339B2 (ja) 2011-01-28 2016-07-20 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 熱硬化剤としてオキシムスルホネートを含む重合性組成物
KR20150138212A (ko) * 2013-03-29 2015-12-09 데이진 화-마 가부시키가이샤 피라졸 유도체
US10487050B2 (en) 2014-08-29 2019-11-26 Basf Se Oxime sulfonate derivatives
BR112017023170B1 (pt) 2015-04-29 2022-08-16 Bsn Medical Gmbh Dispositivo de banho medicinal e seu uso
JP6942058B2 (ja) 2015-04-29 2021-09-29 ビーエスエヌ メディカル ゲーエムベーハー Ｎｏ生成のための多段階プロセス

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178604A (en) * 1966-03-21 1970-01-21 American Cyanamid Co Novel Pyridinium Salts and Methods for Preparing Same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
GB1192701A (en) * 1968-03-22 1970-05-20 Ici Ltd Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same
US3681498A (en) * 1970-10-19 1972-08-01 American Cyanamid Co Isothiazolyl pyridinium salts as hypoglycemic agents

Also Published As

Publication number Publication date
JPS5785379A (en) 1982-05-28
ATE7657T1 (de) 1984-06-15
DD201790A5 (de) 1983-08-10
RO82216A (ro) 1983-07-07
ES505678A0 (es) 1982-12-01
EP0048615A1 (en) 1982-03-31
GB2084573B (en) 1984-09-12
PL233103A1 (cs) 1982-12-20
GR75046B (cs) 1984-07-12
DK417981A (da) 1982-03-23
PT73711B (en) 1982-12-20
ES8301225A1 (es) 1982-12-01
PL130497B1 (en) 1984-08-31
RO82216B (ro) 1983-06-30
FI812940A7 (fi) 1982-03-23
ZA816549B (en) 1983-04-27
PT73711A (en) 1981-10-01
GB2084573A (en) 1982-04-15
US4346094A (en) 1982-08-24
KR830007597A (ko) 1983-11-04
FI812940L (fi) 1982-03-23
EP0048615B1 (en) 1984-05-30
AU7551681A (en) 1982-04-01
IL63890A0 (en) 1981-12-31
DE3163900D1 (en) 1984-07-05
NO813208L (no) 1982-03-23
CS228536B2 (en) 1984-05-14
AR229103A1 (es) 1983-06-15

Similar Documents

Publication Publication Date Title
YU221681A (en) Process for obtaining n-arylbenzamide derivatives
YU43051B (en) Process for preparing 1-sulfo-2-oxo-azetidine derivatives
PT73186B (en) Process for preparing pyrazolopyrydazine derivatives
YU98081A (en) Process for obtaining imidosulfamide derivatives
DE3160156D1 (en) Process for preparing vinylphosphonic-acid derivatives
YU105183A (en) Process for obtaining 2-guanidino-4-heteroarylthiazoles
YU221581A (en) Process for obtaining isoxazolyl-benzamides
YU164481A (en) Process for obtaining isoxazolyl-imidazolidinone
YU228886A (en) Process for obtaining new alphasulphonyloxiketone-acethale
YU42592B (en) Process for preparing 3-amino-propoxyphenyl derivatives
YU81181A (en) Process for obtaining substituted derivatives
PT73113B (en) Process for preparing substituted phenoxy-aminopropanol derivatives
YU217582A (en) Process for obtaining azolyl-pentene derivatives
PT74153B (en) Process for preparing oxadiazolopyrimidine derivatives
YU252981A (en) Process for obtaining 11-dodecene-1-yl derivatives
YU159481A (en) Process for preparing dibenzindole derivatives
YU243681A (en) Process for obtaining buspyrone
YU42413B (en) Process for obtaining dephenylether derivatives
SG65486G (en) Process for preparing 16-hydroxy-17-aminoprepnane derivatives
PT73457A (en) Process for preparing heteroprostaglandin derivatives
YU246381A (en) Process for obtaining cephalexine derivatives
YU42584B (en) Process for obtaining 4-carbamoyloxy-oxazaphosphorine
YU184881A (en) Process for obtaining 4-amino-12-dihydrocarbyl-pyrazolidine
YU71081A (en) Process for obtaining 2-haloacetamides
YU44817B (en) Process for obtaining l-asparagyl-d-amino-acid derivatives